Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.

Zgheib NK, Shamseddine AA, Geryess E, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, El-Saghir NS.

Mutat Res. 2013 Jul-Aug;747-748:40-7. doi: 10.1016/j.mrfmmm.2013.04.004. Epub 2013 Apr 27.

PMID:
23628324
3.

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.

Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K.

Mutat Res. 2005 Jul 1;574(1-2):112-23. Epub 2005 Apr 15.

PMID:
15914211
4.

Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.

Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM.

Int J Hyg Environ Health. 2003 Jun;206(3):149-71. Review.

PMID:
12872524
5.

[Genetic polymorphisms of the CYP450 1A1, CYP450 2E1, GSTM1, GSTT1, and GSTP1 in Korean].

Xu QS, Hong YC, Lee KH.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Jun;22(3):347-9. Chinese.

PMID:
15952134
6.

Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India.

Pandey SN, Jain M, Nigam P, Choudhuri G, Mittal B.

Biomarkers. 2006 May-Jun;11(3):250-61.

PMID:
16760134
7.

Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.

Wu SH, Tsai SM, Hou MF, Lin HS, Hou LA, Ma H, Lin JT, Yeh FL, Tsai LY.

Breast Cancer Res Treat. 2006 Nov;100(1):93-8. Epub 2006 Jun 7.

PMID:
16758119
8.

Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.

Forestiero FJ, Cecon L, Hirata MH, de Melo FF, Cardoso RF, Cerda A, Hirata RD.

Clin Chim Acta. 2013 Jan 16;415:215-9. doi: 10.1016/j.cca.2012.10.030. Epub 2012 Oct 22.

9.

Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.

Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D'Ugo D, La Torre G, van Duijn CM, Ricciardi G.

BMC Cancer. 2007 Nov 8;7:206.

10.

N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.

Rodrigo L, Alvarez V, Rodriguez M, Pérez R, Alvarez R, Coto E.

Scand J Gastroenterol. 1999 Mar;34(3):303-7.

PMID:
10232877
11.

Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.

Duarte EC, Ribeiro DC, Gomez MV, Ramos-Jorge ML, Gomez RS.

Anticancer Res. 2008 Mar-Apr;28(2A):1101-6.

12.

Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.

Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B.

Nutr Cancer. 2010;62(6):734-42. doi: 10.1080/01635581003605904.

PMID:
20661821
13.

Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.

De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):14-22.

14.

Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.

Rossini A, Rapozo DC, Soares Lima SC, Guimarães DP, Ferreira MA, Teixeira R, Kruel CD, Barros SG, Andreollo NA, Acatauassú R, Matos HJ, Albano RM, Pinto LF.

Carcinogenesis. 2007 Dec;28(12):2537-42. Epub 2007 Oct 4.

PMID:
17916905
15.

Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.

Costa GN, Magno LA, Santana CV, Konstantinovas C, Saito ST, Machado M, Di Pietro G, Bastos-Rodrigues L, Miranda DM, De Marco LA, Romano-Silva MA, Rios-Santos F.

Mol Diagn Ther. 2012 Aug 1;16(4):241-50. doi: 10.2165/11634480-000000000-00000.

PMID:
22788240
16.

Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.

Honma HN, De Capitani EM, Perroud MW Jr, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L.

Lung Cancer. 2008 Aug;61(2):152-62. doi: 10.1016/j.lungcan.2007.12.014. Epub 2008 Feb 14.

PMID:
18280004
17.

Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.

Safarinejad MR, Shafiei N, Safarinejad SH.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):105-13. doi: 10.1038/pcan.2010.54. Epub 2011 Jan 18.

PMID:
21243008
18.

[Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].

Rusinova GG, Azizova TV, Viazovskaia NS, Glazkova IV, Gur'ianov MIu, Osovets SV.

Radiats Biol Radioecol. 2014 Jul-Aug;54(4):350-9. Russian.

PMID:
25775823
19.

Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.

Longuemaux S, Deloménie C, Gallou C, Méjean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Béroud C, Dupret JM.

Cancer Res. 1999 Jun 15;59(12):2903-8.

20.

Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.

Singla N, Gupta D, Birbian N, Singh J.

Tuberculosis (Edinb). 2014 May;94(3):293-8. doi: 10.1016/j.tube.2014.02.003. Epub 2014 Feb 15.

PMID:
24637014

Supplemental Content

Support Center